These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7688859)

  • 1. Protective effect of sulfoethylglucan against hexavalent chromium.
    Chorvatovicová D; Kováciková Z; Sandula J; Navarová J
    Mutat Res; 1993 Aug; 302(4):207-11. PubMed ID: 7688859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonication: the way to achieve antimutagenic effect of carboxymethyl-chitin-glucan by oral administration.
    Chorvatovicová D; Machová E; Sandula J
    Mutat Res; 1998 Jan; 412(1):83-9. PubMed ID: 9508367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of potassium dichromate mutagenicity by todralazine.
    Gasiorowski K; Szyba K; Wozniak D; Gulanowski B
    Mutagenesis; 1997 Nov; 12(6):411-5. PubMed ID: 9412993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of hexavalent chromium-induced genotoxic damage in peripheral blood of mice by epigallocatechin-3-gallate (EGCG) and its relationship to the apoptotic activity.
    García-Rodríguez Mdel C; Montaño-Rodríguez AR; Altamirano-Lozano MA
    J Toxicol Environ Health A; 2016; 79(1):28-38. PubMed ID: 26713419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium.
    Blasiak J; Kowalik J
    Mutat Res; 2000 Aug; 469(1):135-45. PubMed ID: 10946250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic Effects of Potassium Dichromate as Evaluated by Means of Animal and Plant Bioindicators.
    Rocha C; Cardoso P; Cunha L; Gomes C; Júnior RR; Pinheiro RH; Costa MH; Burbano R
    In Vivo; 2015; 29(6):729-35. PubMed ID: 26546529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs.
    Ueno S; Kashimoto T; Susa N; Furukawa Y; Ishii M; Yokoi K; Yasuno M; Sasaki YF; Ueda J; Nishimura Y; Sugiyama M
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):56-62. PubMed ID: 11141356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressing effects of glucan on micronuclei induced by cyclophosphamide in mice.
    Chorvatovicová D; Navarová J
    Mutat Res; 1992 Jul; 282(3):147-50. PubMed ID: 1378546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
    Cheng L; Sonntag DM; de Boer J; Dixon K
    J Environ Pathol Toxicol Oncol; 2000; 19(3):239-49. PubMed ID: 10983890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less than additive interaction between cigarette smoke and chromium(VI) in inducing clastogenic damage in rodents.
    Balansky RM; D'Agostini F; Izzotti A; De Flora S
    Carcinogenesis; 2000 Sep; 21(9):1677-82. PubMed ID: 10964099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of basal micronucleus frequency and hexavalent chromium effects in fish erythrocytes.
    de Lemos CT; Rödel PM; Terra NR; Erdtmann B
    Environ Toxicol Chem; 2001 Jun; 20(6):1320-4. PubMed ID: 11392142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the yeast glucomannan against cyclophosphamide-induced mutagenicity.
    Chorvatovicová D; Machová E; Sandula J; Kogan G
    Mutat Res; 1999 Jul; 444(1):117-22. PubMed ID: 10477345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation.
    Molina-Jijón E; Zarco-Márquez G; Medina-Campos ON; Zataraín-Barrón ZL; Hernández-Pando R; Pinzón E; Zavaleta RM; Tapia E; Pedraza-Chaverri J
    Toxicology; 2012 Jan; 291(1-3):93-101. PubMed ID: 22115772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamins C and E on toxicity and mutagenicity of hexavalent chromium in rat and guinea pig.
    Chorvatovicová D; Ginter E; Kosinová A; Zloch Z
    Mutat Res; 1991 Jan; 262(1):41-6. PubMed ID: 1986283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
    Ueno S; Susa N; Furukawa Y; Sugiyama M
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carboxymethyl-chitin-glucan on cyclophosphamide induced mutagenicity.
    Chorvatovicová D; Sandula J
    Mutat Res; 1995 Jan; 346(1):43-8. PubMed ID: 7530328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of taurine on oxidative stress parameters and chromium levels altered by acute hexavalent chromium exposure in mice kidney tissue.
    Boşgelmez II; Güvendik G
    Biol Trace Elem Res; 2004; 102(1-3):209-25. PubMed ID: 15621940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplacental effect of stobadine on cyclophosphamide induced micronucleus frequency in mice.
    Chorvatovicová D; Ujházy E
    Mutagenesis; 1995 Nov; 10(6):531-4. PubMed ID: 8596473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of clastogenicity of benzo[a]pyrene and of its trans-7,8-dihydrodiol in mice in vivo by fruits, vegetables, and flavonoids.
    Edenharder R; Krieg H; Köttgen V; Platt KL
    Mutat Res; 2003 Jun; 537(2):169-81. PubMed ID: 12787821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice.
    Mazur L; Czyzewska A
    Mutat Res; 1994 Sep; 309(2):219-23. PubMed ID: 7520979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.